Sprint Nextel Corporation (S), Life Technologies Corp. (LIFE): What Can a Top Hedge Fund’s Top 2 Holdings Do For You?

Page 1 of 2

John Paulson, the billionaire hedge fund manager, is known for maintaining an impressive strength during the sub-prime crisis of 2008. His firm, Paulson & Co, has a market value of $17.72 billion as of March 2013. However, after the sub-prime crisis, the performance of the fund is not very impressive. Its Advantage Fund has generated an average annual return of just 4.1% in the last 5 years. Here is an analysis of Paulson’s top two holdings to see if investors should look to Paulson’s portfolio to strengthen their own. According to the 13F filing with SEC, Paulson’s top two holdings were Sprint Nextel Corporation (NYSE:S) and Life Technologies Corp. (NASDAQ:LIFE)

PAULSON & CO

Company Percentage of Top Holding
Sprint Nextel 8.1%
Life Technologies 5.39%

Will the innovation and expansion strategies adopted by these companies accelerate their growth?

Strong future growth opportunities

Sprint Nextel Corporation (NYSE:S) increased its capital expenditure to approximately $1.8 billion in the first quarter of this year, up from $800 million in the first quarter of previous year. The company has earmarked $1.4 billion in capital for its Network Vision program, which aims to enhance Sprint’s technology to provide a seamless network. This will increase efficiency and network coverage by improving call quality and data transfer speeds.

Furthermore, Sprint Nextel Corporation (NYSE:S) recently launched 4G LTE in 88 cities, and plans to expand that service in an additional 170 cities in the coming months, which will allow the company to offer smartphone users unlimited access to the LTE network. Based on these moves, Sprint estimates it will generate OBIDA of more than $5.2 billion in the current year, up from $4.8 billion in the previous year.

Recently, after a bid hike from SoftBank, DISH Network Corp. (NASDAQ:DISH) dropped its plan to acquire Sprint Nextel Corporation (NYSE:S). FCC approval is the final hurdle to finish this deal. SoftBank increased its bid to $21.6 billion for 78% of the stake in Sprint Nextel Corporation (NYSE:S). Sprint entered into this deal to expand its high-speed 4G LTE service network in a new market.

SoftBank and Sprint together sold 26.5 million phones in the previous year, which is close to its competitors’ numbers: Verizon Communications Inc. (NYSE:VZ) 28.8 million and AT&T Inc. (NYSE:T)’s 26.9 million. With its newly-acquired capacity, Sprint can look for bargains from phone, which will help the company offer aggressive handset and service contract pricing. Of course, this means higher returns; however, this deal isn’t much of an investment opportunity because Softbank has agreed to acquire it at a price of $7.65 per share, and Sprint is currently trading below that at around $7 per share.

On the path of expansion

Life Technologies of California (LTC) and SuzhouRiboLife Sciences (Ribo) entered into a deal on June 19 to develop and manufacture siRNA molecules, with the help of Life’s Invivofectamine Rx delivery technology, for treatment of patients suffering from hepatitis “B.” LTC will receive royalties for every unit of drug produced by Ribo. As one-third of the people suffering worldwide from hepatitis B reside in China, this is a timely solution to a widespread medical need, and as such, it looks as though the deal will prove successful for both parties.

Further, LTC recently acquired Life Science Korea, a major distributor of biotechnology products in South Korea. This acquisition will help the company approach its Korean customers directly, which will increase its footprint in that market. Emerging markets contributed 10% to LTC’s total sales in 2012. With these expansions, revenue from emerging markets is expected to increase at 30% CAGR and will rise to $1.6 billion in 2015.

However, LTC itself is about to be acquired by Thermo Fisher Scientific Inc. (NYSE:TMO) for $13.6 billion. The deal includes LTC’s debt of approximately $9.5 billion and $4 billion of equity. This acquisition will create a powerhouse in bio-pharma lab instrumentation and supplies.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!